NeuroPro Therapeutics is a pharmaceutical company that develops drugs to treat epilepsy and other neurological disorders.
NeuroPro Therapeutics has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
NeuroPro Therapeutics is headquartered in Yachats, United States.
NeuroPro Therapeutics is a pharmaceutical company that develops drugs to treat epilepsy and other neurological disorders.
NeuroPro Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroPro Therapeutics — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/neuropro-therapeutics. Accessed August 16, 2026.
VCBacked. (2023). NeuroPro Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/neuropro-therapeutics
{{cite web |title=NeuroPro Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuropro-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated